ENDONOVO THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
ENDONOVO THERAPEUTICS, INC. (ENDV) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $20.49 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2022-11-21.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2022-11-21
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-06-30 was $20.49K.
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2021-03-31 was $20.47K, a 113.98% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2020-09-30 was $20.49K, a 84.54% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2020-03-31 was $9.57K, a 85.05% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2020 was $57.40K.
- ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2017 was $1.14M.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2021-06-30 | $20.49K 10-Q · filed 2022-11-21 | $40.96K derived: sum of 2 quarters · filed 2022-11-21 | ||
| 2021-03-31 | $20.47K 10-Q · filed 2022-11-21 | |||
| 2020-12-31 | $57.40K 10-K · filed 2022-04-14 | |||
| 2020-09-30 | $20.49K 10-Q · filed 2021-11-19 | |||
| 2020-03-31 | $9.57K 10-Q · filed 2021-11-19 | |||
| 2019-09-30 | $11.10K 10-Q · filed 2020-11-19 | $16.27K derived: sum of 2 quarters · filed 2020-11-19 | $21.44K derived: sum of 3 quarters · filed 2020-11-19 | |
| 2019-06-30 | $5.17K 10-Q · filed 2020-11-19 | $10.34K derived: sum of 2 quarters · filed 2020-11-19 | ||
| 2019-03-31 | $5.17K 10-Q · filed 2020-11-19 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-04-15 | $139.31K derived: sum of 2 quarters · filed 2019-04-15 | $1.14M 10-K · filed 2019-04-15 | |
| 2017-09-30 | $139.31K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-11-09 | $1.14M 10-Q/A · filed 2017-11-09 | ||
| 2017-06-30 | $1.00M 10-Q · filed 2017-08-10 |